Science Explorer Back to mapMap
Discussion
Company · Rehovot · Israel

Vyne Therapeutics (Israel)

vynetherapeutics.comROR OpenAlex
Research works
19
▲ 198% vs 2018-21
Citations
351
18.2 per fractional work
Top-10% rate
8.7%
all institutions 10.0%
Open access
61%
world 40%
International
34%
world 18%
Vyne Therapeutics (Israel)

Not ranked overall: Vyne Therapeutics (Israel) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Vyne Therapeutics (Israel) work in?

In all years, 44% of research at Vyne Therapeutics (Israel) is in Life Sciences, 36% in Health Sciences. Its largest fields are Medicine (36%), Biochemistry, Genetics and Molecular Biology (26%), Engineering (8%). It does 1.9× the world's share of Life Sciences.

Life Sciences: 8 fractional works · 43.7% of its workBiochemistry, Genetics and Molecular Biology: 5 fractional works · 26.0% of its workMolecular Biology: 4 fractional works · 20.5% of its workBiotechnology: 0 fractional works · 2.3% of its workCancer Research: 0 fractional works · 2.0% of its workGenetics: 0 fractional works · 0.9% of its workClinical Biochemistry: 0 fractional works · 0.4% of its workNeuroscience: 1 fractional works · 5.9% of its workCognitive Neuroscience: 1 fractional works · 3.2% of its workNeurology: 0 fractional works · 1.5% of its workSensory Systems: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.6% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 5.2% of its workToxicology: 1 fractional works · 5.2% of its workImmunology and Microbiology: 1 fractional works · 4.9% of its workImmunology: 1 fractional works · 3.1% of its workVirology: 0 fractional works · 1.7% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 0 fractional works · 1.7% of its workPlant Science: 0 fractional works · 1.7% of its workHealth Sciences: 7 fractional works · 36.1% of its workMedicine: 7 fractional works · 35.7% of its workOncology: 2 fractional works · 10.6% of its workSurgery: 1 fractional works · 3.9% of its workPhysiology: 1 fractional works · 3.7% of its workHepatology: 0 fractional works · 2.5% of its workEpidemiology: 0 fractional works · 2.4% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 2.3% of its workImmunology and Allergy: 0 fractional works · 2.0% of its workBiochemistry: 0 fractional works · 1.7% of its workInfectious Diseases: 0 fractional works · 1.7% of its workGenetics: 0 fractional works · 0.9% of its workPharmacology: 0 fractional works · 0.6% of its workOphthalmology: 0 fractional works · 0.6% of its workPathology and Forensic Medicine: 0 fractional works · 0.6% of its workDermatology: 0 fractional works · 0.4% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.4% of its workReproductive Medicine: 0 fractional works · 0.4% of its workPsychiatry and Mental health: 0 fractional works · 0.4% of its workRheumatology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.4% of its workNursing: 0 fractional works · 0.4% of its workNutrition and Dietetics: 0 fractional works · 0.4% of its workPhysical Sciences: 4 fractional works · 20.2% of its workEngineering: 1 fractional works · 7.6% of its workBiomedical Engineering: 1 fractional works · 3.6% of its workElectrical and Electronic Engineering: 0 fractional works · 1.7% of its workAerospace Engineering: 0 fractional works · 1.1% of its workBuilding and Construction: 0 fractional works · 0.6% of its workComputational Mechanics: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workComputer Science: 1 fractional works · 7.3% of its workComputer Graphics and Computer-Aided Design: 1 fractional works · 5.2% of its workComputational Theory and Mathematics: 0 fractional works · 2.1% of its workPhysics and Astronomy: 1 fractional works · 2.7% of its workAstronomy and Astrophysics: 0 fractional works · 1.7% of its workAtomic and Molecular Physics, and Optics: 0 fractional works · 1.0% of its workSmaller subfields together: 0 fractional works · 0.1% of its workChemistry: 0 fractional works · 2.1% of its workSpectroscopy: 0 fractional works · 1.6% of its workInorganic Chemistry: 0 fractional works · 0.6% of its workMaterials Science: 0 fractional works · 0.4% of its workMaterials Chemistry: 0 fractional works · 0.4% of its workEnvironmental Science: 0 fractional works · 0.1% of its workALL ITS WORKVyne Therapeutics(Israel)19fractional works, all years
Life Sciences44%Physical Sciences20%Health Sciences36%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 13 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology526.0%
    2. Neuroscience15.9%
    3. Pharmacology, Toxicology and Pharmaceutics15.2%
    4. Immunology and Microbiology14.9%
    5. Agricultural and Biological Sciences01.7%
    1. Medicine735.7%
    2. Nursing00.4%
    1. Engineering17.6%
    2. Computer Science17.3%
    3. Physics and Astronomy12.7%
    4. Chemistry02.1%
    5. Materials Science00.4%
    6. Environmental Science00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 5.55× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 6.81× its world share, 1 worksImmunology and Micro…Neuroscience: 4.18× its world share, 1 worksNeuroscienceComputer Science: 0.57× its world share, 0 worksComputer ScienceEngineering: 0.27× its world share, 0 worksEngineeringEnvironmental Science: 0.03× its world share, 0 worksEnvironmental SciencePhysics and Astronomy: 1.67× its world share, 0 worksPhysics and AstronomyMedicine: 2.31× its world share, 4 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.8×. Every wedge is a field page.

All 8 fields, with their numbers
  1. Immunology and Microbiology6.81×1 works
  2. Biochemistry, Genetics and Molecular Biology5.55×3 works
  3. Neuroscience4.18×1 works
  4. Medicine2.31×4 works
  5. Physics and Astronomy1.67×0 works
  6. Computer Science0.57×0 works
  7. Engineering0.27×0 works
  8. Environmental Science0.03×0 works

What are the most cited papers from Vyne Therapeutics (Israel)?

The most cited paper from Vyne Therapeutics (Israel) is "Redox-regulated mechanism may account for zerumbone's ability to suppress cancer-cell proliferation." (Alexandra Hoffman, 2002), with 35 citations. Next come "A Novel Phospholipid Derivative of Indomethacin, DP-155 [Mixture of 1-Steroyl and 1-Palmitoyl-2-{6-[1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indolyl acetamido]hexanoyl}-sn-glycero-3-phosophatidyl Choline], Shows Superior Safety and Similar Efficacy in Reducing Brain Amyloid β in an Alzheimer’s Disease Model" (29) and "T Cells Expressing a Modified FcγRI Exert Antibody-Dependent Cytotoxicity and Overcome the Limitations of CAR T-cell Therapy against Solid Tumors" (5).

Most cited papers
#PaperReleasedCitations
1 Redox-regulated mechanism may account for zerumbone's ability to suppress cancer-cell proliferation. Alexandra Hoffman · Carcinogenesis Open access Nov 2002 35
2 A Novel Phospholipid Derivative of Indomethacin, DP-155 [Mixture of 1-Steroyl and 1-Palmitoyl-2-{6-[1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indolyl acetamido]hexanoyl}-sn-glycero-3-phosophatidyl Choline], Shows Superior Safety and Similar Efficacy in Reducing Brain Amyloid β in an Alzheimer’s Disease Model Eran Dvir, Jonathan E. Friedman, Jun Young Lee et al. · Journal of Pharmacology and Experimental Therapeutics 8 Jun 2006 29
3 T Cells Expressing a Modified FcγRI Exert Antibody-Dependent Cytotoxicity and Overcome the Limitations of CAR T-cell Therapy against Solid Tumors Diana Rasoulouniriana, Nadine Santana-Magal, Amit Gutwillig et al. · Cancer Immunology Research Open access 18 Apr 2023 5
4 Effects of Paper on LEP Digital Print Deinking with Alkaline and Neutral Chemistries Manoj K. Bhattacharyya, Hou T. Ng, Laurie S. Mittelstadt et al. · Technical programs and proceedings/Technical program and proceedings Conference paperOpen access 2012 3
5 Digital Labels Printing Udi Chatow, Ronen Samuel · Technical programs and proceedings/Technical program and proceedings Conference paperOpen access 2003 2
All 11 most cited papers, with filters and sorting

Which research topics does Vyne Therapeutics (Israel) publish most on?

By volume in 2022-now: CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses and Functional Brain Connectivity Studies.

CAR-T cell therapy research: 1 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksImmunotherapy and Immune…1Immunotherapy and Immune Responses: 1 fractional worksFunctional Brain Connect…0Functional Brain Connectivity Studies: 0 fractional worksLiver Diseases and Immunity: 0 fractional worksBioinformatics and Genomic Networks: 0 fractional worksComputational Drug Disco…0Computational Drug Discovery Methods: 0 fractional worksLiver Disease Diagnosis and Treatment: 0 fractional worksRNA and protein synthesis mechanisms: 0 fractional worksProtein Degradation and Inhibitors: 0 fractional works
OncologyImmunologyCognitive NeuroscienceHepatology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 1 works
  2. 2 Cancer Immunotherapy and Biomarkers Oncology 1 works
  3. 3 Immunotherapy and Immune Responses Immunology 1 works
  4. 4 Functional Brain Connectivity Studies Cognitive Neuroscience 0 works
  5. 5 Liver Diseases and Immunity Hepatology 0 works
  6. 6 Bioinformatics and Genomic Networks Molecular Biology 0 works
  7. 7 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
  8. 8 Liver Disease Diagnosis and Treatment Epidemiology 0 works
  9. 9 RNA and protein synthesis mechanisms Molecular Biology 0 works
  10. 10 Protein Degradation and Inhibitors Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available60.8%not open39.2%

World: 40% of research is openly available.

with international co-authors34.3%domestic only65.7%

World: 18% is written across borders.

How has Vyne Therapeutics (Israel)'s research output changed?

Output in 2022-2025 was 198% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Vyne Therapeutics (Israel) as a percentage of every work published that year, 0.000017% in 2024.

still counting0.00010%0.00020%0.00030%Vyne Therapeutics (Israel)0.000049% in 20251990200020102020

Fractional works of Vyne Therapeutics (Israel) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Rehovot

All research institutions in Rehovot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Vyne Therapeutics (Israel). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.